(Q46934849)

26 December 2017

review article

1 reference

title

Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy (English)

1 reference

26 December 2017

1 reference

1

1 reference

26 December 2017

author name string

Silvia Piconese

series ordinal

2

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

26 December 2017

published in

Nature Reviews Cancer

1 reference

26 December 2017

volume

7

1 reference

26 December 2017

page(s)

880-887

1 reference

26 December 2017

issue

11

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/nrc2250

exact match

0 references

cites work

On Concomitant Immunity in Tumour-bearing Hamsters

1 reference

Foxp3 in control of the regulatory T cell lineage

31 March 2020

1 reference

Natural regulatory T cells: mechanisms of suppression

31 March 2020

1 reference

Natural versus adaptive regulatory T cells

31 March 2020

1 reference

Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells

31 March 2020

1 reference

Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state

31 March 2020

1 reference

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

31 March 2020

1 reference

Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance

31 March 2020

1 reference

Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

31 March 2020

1 reference

Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells.

31 March 2020

1 reference

Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression.

31 March 2020

1 reference

Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression

31 March 2020

1 reference

31 March 2020

1 reference

Interleukin-10-secreting type 1 regulatory T cells in rodents and humans.

31 March 2020

1 reference

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

31 March 2020

1 reference

Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines

31 March 2020

1 reference

Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent

31 March 2020

1 reference

Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance

31 March 2020

1 reference

An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires

31 March 2020

1 reference

Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors

31 March 2020

1 reference

Role of SEREX-defined immunogenic wild-type cellular molecules in the development of tumor-specific immunity

31 March 2020

1 reference

Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?

31 March 2020

1 reference

CD40/CD40L interaction regulates CD4+CD25+ T reg homeostasis through dendritic cell-produced IL-2.

31 March 2020

1 reference

Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells

31 March 2020

1 reference

Tolerance, not immunity, crucially depends on IL-2.

31 March 2020

1 reference

Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice

31 March 2020

1 reference

Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus

31 March 2020

1 reference

Inducing and expanding regulatory T cell populations by foreign antigen

31 March 2020

1 reference

A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism

31 March 2020

1 reference

Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid

31 March 2020

1 reference

All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation

31 March 2020

1 reference

Induction of Regulatory T Cells and Dominant Tolerance by Dendritic Cells Incapable of Full Activation

31 March 2020

1 reference

Human CD4+ CD25hi Foxp3+ regulatory T cells are derived by rapid turnover of memory populations in vivo

31 March 2020

1 reference

The three Es of cancer immunoediting

31 March 2020

1 reference

Regulatory T cells, tumour immunity and immunotherapy

31 March 2020

1 reference

Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

31 March 2020

1 reference

Generation and decay of the immune response to a progressive fibrosarcoma. II. Failure to demonstrate postexcision immunity after the onset of T cell-mediated suppression of immunity

31 March 2020

1 reference

Both regulatory T cells and antitumor effector T cells are primed in the same draining lymph nodes during tumor progression

31 March 2020

1 reference

Immunosurveillance of Erbb2 carcinogenesis in transgenic mice is concealed by a dominant regulatory T-cell self-tolerance

31 March 2020

1 reference

The impact of regulatory T cells on carcinogen-induced sarcogenesis

31 March 2020

1 reference

CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer

31 March 2020

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

31 March 2020

1 reference

Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma

31 March 2020

1 reference

CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression

31 March 2020

1 reference

Characteristics of CD4+CD25+ regulatory T cells in the peripheral circulation of patients with head and neck cancer

31 March 2020

1 reference

Comparative analysis of regulatory and effector T cells in progressively growing versus rejecting tumors of similar origins

31 March 2020

1 reference

Tumor evasion of the immune system by converting CD4+CD25- T cells into CD4+CD25+ T regulatory cells: role of tumor-derived TGF-beta

31 March 2020

1 reference

The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells

31 March 2020

1 reference

In vivo peripheral expansion of naive CD4+CD25high FoxP3+ regulatory T cells in patients with multiple myeloma.

31 March 2020

1 reference

Distinct subsets of FoxP3+ regulatory T cells participate in the control of immune responses.

31 March 2020

1 reference

Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens

31 March 2020

1 reference

CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine

31 March 2020

1 reference

Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma

31 March 2020

1 reference

Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation

31 March 2020

1 reference

Regulatory T cells in ovarian cancer: biology and therapeutic potential

31 March 2020

1 reference

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

31 March 2020

1 reference

Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma

31 March 2020

1 reference

Depletion of CD4+CD25+ human regulatory T cells in vivo: kinetics of Treg depletion and alterations in immune functions in vivo and in vitro

31 March 2020

1 reference

A denileukin diftitox (Ontak) associated retinopathy?

31 March 2020

1 reference

Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2.

31 March 2020

1 reference

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

31 March 2020

1 reference

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

31 March 2020

1 reference

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

31 March 2020

1 reference

Inhibition of indoleamine 2,3-dioxygenase in dendritic cells by stereoisomers of 1-methyl-tryptophan correlates with antitumor responses

31 March 2020

1 reference

Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy.

31 March 2020

1 reference

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

31 March 2020

1 reference

TGF-beta directly targets cytotoxic T cell functions during tumor evasion of immune surveillance

31 March 2020

1 reference

Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors

31 March 2020

1 reference

Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells.

31 March 2020

1 reference

Glucocorticoid-induced TNF receptor family related gene activation overcomes tolerance/ignorance to melanoma differentiation antigens and enhances antitumor immunity.

31 March 2020

1 reference

Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo

31 March 2020

1 reference

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

31 March 2020

1 reference

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

31 March 2020

1 reference

Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function

31 March 2020

1 reference

Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.

31 March 2020

1 reference

A2A adenosine receptor protects tumors from antitumor T cells.

31 March 2020

1 reference

Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRC2250

1 reference

26 December 2017

PubMed ID

17957190

1 reference

26 December 2017